Downloadable figures: Antimicrobial consumption – Annual Epidemiological Report for 2016
Data from the 'Antimicrobial consumption - Annual Epidemiological Report for 2016'.
Download
Available figures
Figure D1. Consumption of broad- and narrow-spectrum penicillins (ATC group J01C) for systemic use in the community, EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day
Figure D2. Consumption of first-, second-, third- and fourth-generation cephalosporins (ATC group J01DB-DE) for systemic use in the community, EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day
Figure D3. Consumption of short-, intermediate- and long-acting macrolides (ATC group J01F) for systemic use in the community, EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day
Figure D4. Consumption of first-, second- and third-generation quinolones (ATC group J01M) for systemic use in the community, EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day
Figure D5. Consumption of antimycotics (ATC group J02) and antifungals (ATC group D01B) for systemic use in the community, EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day
Figure D6. Consumption of antimycotics (ATC group J02) and antifungals (ATC group D01B) for systemic use in the hospital sector, EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day
Figure D7. Consumption of antivirals for systemic use (ATC group J05) in both sectors (community and hospital sector), grouped into categories of their main indication, EU/EEA countries, 2016, expressed as DDD per 1 000 inhabitants per day